March 24, 2020 / 12:38 PM / 17 days ago

BRIEF-Gossamer Bio Announces Fourth Quarter And Full-Year 2019 Financial Results And Provides Business Update

March 24 (Reuters) - Gossamer Bio Inc:

* GOSSAMER BIO ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.89

* Q4 EARNINGS PER SHARE ESTIMATE $-0.86 — REFINITIV IBES DATA

* GOSSAMER BIO - CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES TOTALED $401.8 MILLION AT YEAR-END 2019

* DUE TO ONGOING COVID-19 VIRAL PANDEMIC, PHASE 2 STUDY IN PATIENTS WITH PAH TO LIKELY COMMENCE IN SECOND HALF OF YEAR

* GOSSAMER BIO - IN RESPONSE TO ONGOING COVID-19 VIRAL PANDEMIC, PLANNED SERIES OF COST-OPTIMIZATION INITIATIVES

* GOSSAMER BIO - SEE CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES TO BE SUFFICIENT TO FUND OPERATING & CAPITAL EXPENDITURES TO MIDDLE OF 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below